The sex life of women surviving breast cancer

References

• Ghizzani A, Pirtoli L, Bellezza A, et al. The evaluation of some factors influencing the sexual life of women affected by breast cancer. J Sex Mar Ther. 1995;21:57–63.
   PubMed Web of Science ®Google Scholar
• Dittrich C, Kosty M, Jezdic S, et al. ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition. ESMO Open. 2016;1:e000097.
   PubMed Web of Science ®Google Scholar
• Gass J, Dupree B, Pruthi S, et al. Breast cancer survivorship: why, what and when? Ann Surg Oncol. 2016;23:3162–3167.
   PubMedGoogle Scholar
• Leslie S. The impact of breast cancer on sexuality, body image, and intimate relationship. CA Cancer J Clin. 1991;41:112–120.
   PubMed Web of Science ®Google Scholar
• Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor: lost in transition. IOM Report. Washington (DC): The National Academies Press; 2006. p. 9–186.
   Google Scholar
• Gilbert E, Ussher JM, Perz J. Sexuality after breast cancer: a review. Maturitas. 2010;66:397–407.
   PubMed Web of Science ®Google Scholar
• McClelland SI, Holland KJ, Griggs JJ. Quality of life and metastatic breast cancer: the role of body image, disease site, and time since diagnosis. Qual Life Res. 2015;24:2939–2943.
   PubMed Web of Science ®Google Scholar
• Male DA, Fergus KD, Cullen K. Sexual identity after breast cancer: sexuality, body image and relationship repercussions. Curr Opin Support Palliat Care. 2016;10:66–74.
   PubMed Web of Science ®Google Scholar
• Rojas K, Onstad M, Raker C, et al. The impact of mastectomy type on the Female Sexual Function Index (FSFI), satisfaction with appearance and the reconstructed breast’s role in intimacy. Breast Cancer Res Treat. 2017;163:273–279.
   PubMed Web of Science ®Google Scholar
• Bykowski MR, Emelife PI, Emelife NN, et al. Nipple-areola complex reconstruction improves psychosocial and sexual well-being in women treated for breast cancer. J Plast Reconstr Aesthet Surg. 2017;70:209–214.
   PubMed Web of Science ®Google Scholar
• Unukovych D, Johansson H, Brandberg Y. Preoperative psychosocial characteristics may predict body image and sexuality two years after risk-reducing mastectomy: a prospective study. Gland Surg. 2017;6:64–72.
   PubMed Web of Science ®Google Scholar
• Zdenkowski N, Tesson S, Lombard J, et al. Supportive care of women with breast cancer: key concerns and practical solutions. Med J Aust. 2016;205:471–475.
   PubMed Web of Science ®Google Scholar
• Lemieux J, Goodwin PJ, Bordeleau LJ, et al. Quality-of-life measurement in randomized clinical trials in breast cancer: an updated systematic review. J Natl Cancer Inst. 2011;103:178–231.
   PubMedGoogle Scholar
• Di Lascio S, Pagani O. Is it time to address survivorship in advanced breast cancer? A review article. Breast. 2017;31:167–172.
   PubMed Web of Science ®Google Scholar
• Keesing S, Rosenwax L, McNamara B. A dyadic approach to understanding the impact of breast cancer on relationships between partners during early survivorship. BMC Women’s Health. 2016;16:57.
   PubMed Web of Science ®Google Scholar
• Kaplan HS. A neglected issue: the sexual side effects of current treatments for breast cancer. J Sex Marital Ther. 1992;18:3–19.
   PubMed Web of Science ®Google Scholar
• Schover LR, van der Kaaij M, van Dorst E, et al. Sexual dysfunction and infertility as late effects of cancer treatment. EJC. 2014;12:41–53.
   PubMedGoogle Scholar
• Tryfonidis K, Zardavas D, Katzenellenbogen BS, et al. Endocrine treatment in breast cancer: cure, resistance and beyond. Cancer Treat Rev. 2016;50:68–81.
   PubMed Web of Science ®Google Scholar
• Li JJ, Shao ZM. Endocrine therapy as adjuvant or neoadjuvant therapy for breast cancer: selecting the best agents, the timing and duration of treatment. Chin Clin Oncol. 2016;5:40.
   PubMed Web of Science ®Google Scholar
• Colleoni M, Giobbie-Hurder A. Benefits and adverse effects of endocrine therapy. Ann Oncol. 2010;21:107–111.
   Web of Science ®Google Scholar
• Sousa MS, Peate M, Jarvis S, et al. A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapy. Ther Adv Med Oncol. 2017;9:269–285.
   PubMed Web of Science ®Google Scholar
• Baumgart J, Nilsson K, Evers AS, et al. Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer. Menopause. 2013;20:162–168.
   PubMed Web of Science ®Google Scholar
• Cohen PA, Brennan A, Marino JL, et al. Managing menopausal symptoms after breast cancer – a multidisciplinary approach. Maturitas. 2017;105:4–7.
   PubMed Web of Science ®Google Scholar
• Holmberg L, Iversen OE, Rudenstam CM, et al. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J Natl Cancer Inst. 2008;100:475–482.
   PubMed Web of Science ®Google Scholar
• Fahlen M, Fornander T, Johansson H, et al. Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial. Eur J Cancer. 2013;49:52–59.
   PubMed Web of Science ®Google Scholar
• Kenemans P, Bundred NJ, Foidart JM, et al. Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial. Lancet Oncol. 2009;10:135–146.
   PubMed Web of Science ®Google Scholar
• Sinha A, Ewies AA. Non-hormonal topical treatment of vulvovaginal atrophy: an up-to-date overview. Climacteric. 2013;6:305–312.
   Google Scholar
• Falk SJ, Bober S. Vaginal health during breast cancer treatment. Curr Oncol Rep. 2016;18:32.
   PubMed Web of Science ®Google Scholar
• Santen RJ, Stuenkel CA, Davis SR, et al. Managing menopausal symptoms and associated clinical issues in breast cancer survivors. J Clin Endocrinol Metab. 2017;102:3647–3661.
   PubMed Web of Science ®Google Scholar
• Wurz GT, Soe LH, DeGregorio MW. Ospemifene, vulvovaginal atrophy, and breast cancer. Maturitas. 2013;74:220–225.
   PubMed Web of Science ®Google Scholar
• Stuenkel CA, Davis SR, Gompel A, et al. Treatment of symptoms of the menopause: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:3975–4011.
   PubMed Web of Science ®Google Scholar
• Schover LR. Sexuality and body image in younger women with breast cancer. J Natl Cancer Inst Monogr. 1994;16:177–182.
   PubMedGoogle Scholar
• Maurice WL. Intercourse difficulties in women: pain, discomfort, and fear. Chapter 13. In: Sexual medicine in primary care. St. Louis (MO): Mosby; 1999. p. 277–298.
   Google Scholar
• Rosenbaum TY. Physiotherapy treatment of sexual pain disorders. J Sex Marital Ther. 2005;31:329–340.
   PubMed Web of Science ®Google Scholar
• Albaugh JA, Kellogg-Spadt S. Sensate focus and its role in treating sexual dysfunction. Urol Nurs. 2002;22:402–403.
   PubMedGoogle Scholar
• De Villers L, Turgeon H. The uses and benefits of “sensate focus” exercises. Contemp Sexual. 2005;39:11.
   Google Scholar
• Kaplan HS. An erotic technique used for many dysfunctions, chap. 3. In: The illustrated manual of sex therapy. New York City: Quadrangle; 1975. p. 29–45.
   Google Scholar
• Kaplan HS. Sensate focus II – genital pleasuring, chap. 4. In: The illustrated manual of sex therapy. New York City: Quadrangle; 1975. p. 46–57.
   Google Scholar
• Hummel SB, Van Lankveld JJDM, Oldenburg HSA, et al. Efficacy of Internet-based cognitive behavioral therapy in improving sexual functioning of breast cancer survivors: results of a randomized controlled trial. J Clin Oncol. 2017;35:1328–1340.
   PubMedGoogle Scholar
• Scott JL, Kayser K. A review of couple-based interventions for enhancing women’s sexual adjustment and body image after cancer. Cancer J. 2009;15:48–56.
   PubMed Web of Science ®Google Scholar